These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 26574717)

  • 21. New Therapies for Emerging Endotypes of Asthma.
    Chupp GL; Kaur R; Mainardi A
    Annu Rev Med; 2020 Jan; 71():289-302. PubMed ID: 31689153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implications of asthma endotypes and phenotypes.
    Taunk ST; Cardet JC; Ledford DK
    Allergy Asthma Proc; 2022 Sep; 43(5):375-382. PubMed ID: 36065106
    [No Abstract]   [Full Text] [Related]  

  • 23. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome.
    Lötvall J; Akdis CA; Bacharier LB; Bjermer L; Casale TB; Custovic A; Lemanske RF; Wardlaw AJ; Wenzel SE; Greenberger PA
    J Allergy Clin Immunol; 2011 Feb; 127(2):355-60. PubMed ID: 21281866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current and future targeted therapies for severe asthma: Managing treatment with biologics based on phenotypes and biomarkers.
    Santus P; Saad M; Damiani G; Patella V; Radovanovic D
    Pharmacol Res; 2019 Aug; 146():104296. PubMed ID: 31173886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Advances in Severe Asthma: From Phenotypes to Personalized Medicine.
    Schoettler N; Strek ME
    Chest; 2020 Mar; 157(3):516-528. PubMed ID: 31678077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subclinical phenotypes of asthma.
    Bradding P; Green RH
    Curr Opin Allergy Clin Immunol; 2010 Feb; 10(1):54-9. PubMed ID: 19907311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is there a role for macrolides in severe asthma?
    Brusselle GG; Joos G
    Curr Opin Pulm Med; 2014 Jan; 20(1):95-102. PubMed ID: 24247040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotypes and endotypes of uncontrolled severe asthma: new treatments.
    Campo P; Rodríguez F; Sánchez-García S; Barranco P; Quirce S; Pérez-Francés C; Gómez-Torrijos E; Cárdenas R; Olaguibel JM; Delgado J; ;
    J Investig Allergol Clin Immunol; 2013; 23(2):76-88; quiz 1 p. follow 88. PubMed ID: 23654073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular phenotyping and biomarker development: are we on our way towards targeted therapy for severe asthma?
    De Ferrari L; Chiappori A; Bagnasco D; Riccio AM; Passalacqua G; Canonica GW
    Expert Rev Respir Med; 2016; 10(1):29-38. PubMed ID: 26566089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease.
    Kuruvilla ME; Lee FE; Lee GB
    Clin Rev Allergy Immunol; 2019 Apr; 56(2):219-233. PubMed ID: 30206782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of severe asthma: entering the era of targeted therapy.
    van Buul AR; Taube C
    Expert Opin Biol Ther; 2015; 15(12):1713-25. PubMed ID: 26331583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Issues in Severe Asthma: Debates and Discussions About Personalizing Patient Management.
    Panettieri RA; Wechsler ME; Wenzel SE
    Chest; 2018 Dec; 154(6):1459-1460. PubMed ID: 30526975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New concepts in asthma: clinical phenotypes and pathophysiological mechanisms.
    Koczulla AR; Vogelmeier CF; Garn H; Renz H
    Drug Discov Today; 2017 Feb; 22(2):388-396. PubMed ID: 27867084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity and adult asthma: diagnostic and management challenges.
    Grace J; Mohan A; Lugogo NL
    Curr Opin Pulm Med; 2019 Jan; 25(1):44-50. PubMed ID: 30394901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The concepts of asthma endotypes and phenotypes to guide current and novel treatment strategies.
    Ozdemir C; Kucuksezer UC; Akdis M; Akdis CA
    Expert Rev Respir Med; 2018 Sep; 12(9):733-743. PubMed ID: 30084271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biologic Therapy and Novel Molecular Targets of Severe Asthma.
    Pepper AN; Renz H; Casale TB; Garn H
    J Allergy Clin Immunol Pract; 2017; 5(4):909-916. PubMed ID: 28689841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Th2 cytokine antagonists: potential treatments for severe asthma.
    Hansbro PM; Scott GV; Essilfie AT; Kim RY; Starkey MR; Nguyen DH; Allen PD; Kaiko GE; Yang M; Horvat JC; Foster PS
    Expert Opin Investig Drugs; 2013 Jan; 22(1):49-69. PubMed ID: 23126660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe asthma: epidemiology, burden of illness, and heterogeneity.
    Lang DM
    Allergy Asthma Proc; 2015; 36(6):418-24. PubMed ID: 26534747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe asthma in children: Current goals and unmet needs.
    Licari A; Manti S; Chiappini E; Ciprandi G; Marseglia GL
    Pediatr Allergy Immunol; 2020 Feb; 31 Suppl 24():40-42. PubMed ID: 32017220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular T2 asthma phenotypes are stable but heterogeneous: the usefulness of periostin for endotyping.
    Bobolea I; Guillén-Vera D; De Las Cuevas-Moreno N; García-Granero DB; Loli-Ausejo D; Melero-Moreno C
    Front Allergy; 2023; 4():1205115. PubMed ID: 37744693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.